Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates


Follow the latest updates of the outbreak on our timeline.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

A study conducted by Chinese researchers has revealed that asymptomatic carriers of coronavirus Covid-19 could transmit the virus.

Published in JAMA Network, the study involves a 20-year-old woman from Wuhan who was not physically sick but passed the infection to five of her family members.

In January, the research team recruited a familial cluster of five patients with fever and respiratory symptoms in Anyang, China. All patients received chest CT imaging and reverse transcriptase-polymerase chain reaction (RT-PCR) tests.

The 20-year-old woman (patient 1) travelled to Anyang on 10 January and came in contact with patients 2 and 3. The woman then travelled with patients 2 to 6 on 13 January.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

All five family members (patients 2 to 6), who never visited Wuhan or had contact with other people who had travelled to Wuhan, developed Covid-19. They developed fever and respiratory symptoms between 23 January and 26 January. All these patients tested positive within one day

However, patient 1 tested negative on 26 January, positive on 28 January and negative on 5 and 8 February. The incubation period for this patient is 19 days and her first RT-PCR result was negative.

Based on results, researchers said: “If the findings in this report of presumed transmission by an asymptomatic carrier are replicated, the prevention of Covid-19 infection would prove challenging.

“The mechanism by which asymptomatic carriers could acquire and transmit the coronavirus that causes Covid-19 requires further study.”

A separate report showed that the incubation period of the novel Covid-19 coronavirus could be as long as 27 days.

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact